Physician profile
Marlene E Mires
NPI 1235185976
$2,255.47
in general payments reported to CMS, 2019-2025
29 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,362 · 2020: $278 · 2022: $13.02 · 2024: $188 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $397.79 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $232.85 | 2019-2025 | Farxiga |
| Glaxosmithkline, LLC. | $213.44 | 2019-2024 | Trelegy Ellipta |
| Lilly USA, LLC | $178.99 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $144.74 | 2019-2024 | |
| Nova Eye, INC. | $125.00 | 2025 | |
| Amgen INC. | $110.83 | 2019-2025 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.52 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $98.94 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $64.76 | 2025 | |
| Janssen Pharmaceuticals, INC | $63.90 | 2019 | |
| Radius Health, INC. | $47.95 | 2019 | |
| Bausch Health US, LLC | $45.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.92 | 2019-2020 | |
| Astellas Pharma US INC | $42.77 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $37.81 | 2019 | |
| Sanofi Pasteur INC. | $37.34 | 2019 | |
| Amag Pharmaceuticals, INC. | $36.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.91 | 2019 | |
| Valeritas, INC. | $23.61 | 2019 | |
| Irhythm Technologies, INC. | $21.64 | 2019 | |
| Intra-Sana Laboratories | $21.39 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Hologic Sales and Service, LLC | $21.20 | 2020 | |
| Ibsa Pharma INC. | $20.74 | 2019 | |
| Avanir Pharmaceuticals, INC. | $20.59 | 2019 | |
| Therapeuticsmd, INC. | $19.06 | 2019 | |
| Scilex Pharmaceuticals INC. | $18.77 | 2019 | |
| Allergan, INC. | $16.96 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Mires listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.